immunology
Clinical Applications of DNA Vaccines: Current Progress CC BY-NC-ND Bernadette Ferraro, Matthew P. Morrow, Natalie A. Hutnick
Rp3
Effect of Preexisting Immunity to Adenovirus Human Serotype 5 Antigens on the Immune Responses of Nonhuman Primates to Vaccine
Rp3
Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune re
Rp3
Antibody purification handbook CC NY 4.0 Creative Commons License GE Healthcare 2007 GE Healthcare Bio-Sciences AB
Rp3
Vaccine Development Using Recombinant DNA Technology CC BY-NC-ND Mark W. Jackwood Leslie Hickle Sanjay Kapil Robert Silva Kla
Rp3
Protocol VRC 308 (NIH 09-I-0204) An Open-Label Phase I Study of the Safety and Immunogenicity of Investigational H1 DNA Influen
Rp3
2009 ASNM Conference Program (1st Annual Conference), Oct 22-25, 2009, Potomac, Maryland American Society for Nanomedicine 2
Rp3
CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein CC-BY-NC-ND 4.0 Internation
Rp3
Adenovirus-Based Vaccines: Comparison of Vectors from Three Species of Adenoviridae CC BY-ND 3.0 Vol. 84, No. 20 H. Chen †,
Rp3
SARS coronavirus polypeptide antigen and application thereof / Removal of nucleic acids from monoclonal antibody preparations
Rp3
Reverse Vaccinology: Developing Vaccines in the Era of Genomics CC BY-NC-ND Alessandro Sette, Rino Rappuoli 2010 Journal of
Rp3
The immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8+ T cells are augmented in varying degrees by CpG
Rp3
Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models CC-BY-NC-ND 4.0 Int
Rp3
Vaccine-nation; Poisoning the Population, One Shot at a Time Andreas Moritz 2011 Ener-Chi Wellness Press 9780984595426, 098
Rp3
Developing vaccines in the era of genomics: a decade of reverse vaccinology CC BY-NC-ND K. L. Seib, X. Zhao, R. Rappuoli 2012
Rp3
Primer to the Immune Response Tak Mak, Mary Saunders, Bradley Jett 2013 Academic Cell 0123852455, 9780123852458, 9780123854
Rp3
Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants CC BY-NC-ND Seleeke Fl
Rp3
Evolution of B Cell Immunity CC BY-NC-ND David Parra, Fumio Takizawa, J. Oriol Sunyer 2013 Annual Review of Animal Bioscienc
Rp3
Intranasal vaccination with recombinant receptor-binding domain ofMERS-CoV spike protein induces much stronger local mucosalimm
Rp3
Hell-Bent Obsession, Pain, and the Search for Something Like Transcendence in Competitive Yoga by Benjamin Benjamin Lorr 201
Rp3
A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome cor
Rp3
Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preli
Rp3
Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design CC BY-NC-ND Rino Rappuoli, Matthew J. Bottomley, U
Rp3
Novel, Chimpanzee Serotype 68-Based Adenoviral Vaccine Carrier for Induction of Antibodies to a Transgene Product CC BY-NC-ND
Rp3
Coronavirus (SARS-CoV-2) lgG/lgM Nucleocapsid (N) Protein Rapid Test Casette (Whole Blood/Serum/Plasma) Package Insert In Vitro
Rp3
Drug and vaccine design against Novel Coronavirus (2019-nCoV) spike protein through Computational approach CC BY-NC-ND Suresh
Rp3
Ebola virus EBOV (Subtype Sudan, strain Gulu) Glycoprotein / GP1 (mucin domain deleted) HEK293 Cell Lysate (WB positive control
Rp3
The Road from Nanomedicine to Precision Medicine (October 21, 2019) - 17th Annual Int Conf of the American Society for Nanomedi
Rp3
Antibody Purification and Labeling CC BY-NC-ND Promega Promega
Rp3
Evaluation of BBG2Na in infant macaques: specific immune responses after vaccination and RSV challenge CC BY-NC-ND L. de Waal
Rp3